Global Nerve Monitoring Systems Market (2021 to 2026) - Featuring Medtronic, Natus Medical and Nuvasive Among Others prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Xtalks Announces Its Life Science Webinar Calendar for June 2021
Share Article
Upcoming free, educational webinars from Xtalks Webinars will feature topics on biomarkers, clinical trials, drug discovery & development, healthcare, laboratory technology, patient recruitment & retention, pharmaceutical, pharma manufacturing & supply chain, medical devices and food. TORONTO (PRWEB) June 01, 2021 Stay on top of current hot topics through free webinars presented by leading experts in pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Visit http://www.xtalks.com to see our upcoming webinars:
Construction Recovery in Full Swing as Proposal Activity Soars - PSMJ Survey
Share Article
PSMJ Resources Quarterly Market Forecast found record-setting growth in proposal activity across many markets and submarkets for the 1st Quarter of 2021, with Housing leading the way. NEWTON, Mass. (PRWEB) May 13, 2021 Proposal activity for architecture, engineering and construction (A/E/C) firms improved for all markets and nearly all submarkets in the 1st Quarter of 2021, with its overall Net Plus/Minus Index (NPMI) rising from 5% in the 4th Quarter of 2020 to a near-record 51%.
“It’s time to party like it’s 2019,” says PSMJ Senior Principal David Burstein, PE, AECPM. “For the first time since the pandemic began, proposal activity in all major market sectors is increasing. Even sectors that had been slow prior to the pandemic, such as education, are now picking up steam. There are still a few submarkets that h
Jushi Holdings to Acquire Nature’s Remedy in Massachusetts
Chris Furnari - Apr 19, 2021 at 12:06 PM
Jushi Holdings will enter the Massachusetts cannabis market via the acquisition of Nature’s Remedy, a vertically integrated operator with two adult-use retail dispensaries and a 50,000 sq. ft. cultivation and processing facility.
The cash-and-stock transaction is valued at $110 million, and includes a $40 million cash payment, $55 million in stock and a $5 million promissory note.
An additional $10 million in stock-based milestone payments is also up for grabs once the deal closes during the second half of 2021.
“This acquisition will enable us to rapidly build scale in an important, maturing adult-use market with a defensible retail position and a solid cultivation footprint with significant opportunities to expand,” Jushi CEO Jim Cacioppo said in a news release.